Large‐scale purification of functional recombinant human aquaporin‐2

FEBS Letters - Tập 504 - Trang 200-205 - 2001
Paul J.L. Werten1, Lorenz Hasler2, Jan B. Koenderink3, Corné H.W. Klaassen3, Willem J. de Grip3, Andreas Engel2, Peter M.T. Deen1
1Department of Cell Physiology, University of Nijmegen, Nijmegen, The Netherlands
2ME Müller Institut, Biozentrum, Universität Basel, Basel, Switzerland
3Department of Biochemistry, University of Nijmegen, Nijmegen The Netherlands

Tóm tắt

The homotetrameric aquaporin‐2 (AQP2) water channel is essential for the concentration of urine and of critical importance in diseases with water dysregulation, such as nephrogenic diabetes insipidus, congestive heart failure, liver cirrhosis and pre‐eclampsia. The structure of human AQP2 is a prerequisite for understanding its function and for designing specific blockers. To obtain sufficient amounts of AQP2 for structural analyses, we have expressed recombinant his‐tagged human AQP2 (HT‐AQP2) in the baculovirus/insect cell system. Using the protocols outlined in this study, 0.5 mg of pure HT‐AQP2 could be obtained per liter of bioreactor culture. HT‐AQP2 had retained its homotetrameric structure and exhibited a single channel water permeability of 0.93±0.03×10−13 cm3/s, similar to that of other AQPs. Thus, the baculovirus/insect cell system allows large‐scale expression of functional recombinant human AQP2 that is suitable for structural studies.


Tài liệu tham khảo

10.1006/jmbi.1999.3413 10.1016/S1357-4310(99)01636-6 10.1016/S0955-0674(98)80055-0 10.1681/ASN.V114764 10.1093/ndt/13.7.1645 10.1097/00041552-199801000-00007 10.1097/00041552-199707000-00010 10.1097/00041552-199809000-00005 10.1172/JCI2605 10.1126/science.8140421 10.1681/ASN.V103647 10.1097/00005768-199808000-00008 10.1073/pnas.94.10.5450 Schrier R.W., 1998, Proc. Assoc. Am. Physicians, 110, 407 10.1152/ajprenal.1998.275.2.F216 10.1002/hep.1840210128 10.1681/ASN.V1091950 Pearson J.F., 1992, Br. J. Hosp. Med., 48, 47 10.1006/mgme.1998.2765 10.1107/S0907444900008143 10.1006/jmbi.1999.3031 10.1093/embo-reports/kvd022 10.1111/j.1432-1033.1990.tb15650.x 10.1038/42512 10.1038/361549a0 10.1007/BF01464780 10.1006/abio.1994.1060 10.1042/bj3420293 10.1681/ASN.V8101493 10.1172/JCI117920 10.1083/jcb.126.4.1047 10.1093/emboj/18.9.2394 10.1016/S0021-9258(17)42062-X 10.1007/BF01870707 10.1016/0003-2697(85)90445-2 10.1016/0003-2697(80)90269-9 10.1002/j.1460-2075.1994.tb06597.x 10.1006/jmbi.1999.3293 10.1006/jmbi.1998.1796 10.1016/S0021-9258(18)38133-X 10.1016/S0304-3991(79)80044-3 10.1093/protein/10.6.707 10.1021/bi970231r